U.S. Physical Therapy Balances Growth With Margin Strain

U.s. Physical Therapy ((USPH)) has held its Q1 earnings call. Read on for the main highlights of the call.

U.S. Physical Therapy’s latest earnings call struck a cautiously optimistic tone, as management balanced solid revenue and visit growth with margin pressure and weaker GAAP earnings. Leaders emphasized expanding industrial injury prevention margins, strengthening visit trends, and new hospital affiliations, while acknowledging near-term cost headwinds, weather-related disruptions, and tax impacts that weighed on profitability.

Revenue Growth and Expanding Patient Visits

U.S. Physical Therapy delivered first-quarter revenue of $198.0 million, a 7.9% increase year over year, driven by higher patient volume across its clinic base. Total patient visits climbed 6.9% to 1.543 million, with average daily visits per clinic rising to 31.8 from 31.2, signaling healthier clinic throughput and demand.

Physical Therapy Segment Shows Steady Recovery

Core physical therapy revenue reached $168.0 million, up 7.2% from the prior year, reflecting continued recovery in the company’s largest business. Same-store, or mature clinic, revenue grew 2.5%, extending a sequential improvement trend that management believes will build as seasonality normalizes.

Pricing Gains and Payer Mix Tailwinds

Net patient revenue per visit ticked up to $106.49 from $105.66, a modest gain of about $0.83 that reflects incremental pricing leverage. Commercial revenue per visit climbed 3.4% as nearly half of the payer mix is now commercial, while an expected 1.75% Medicare rate increase is beginning to show through, offering a small but important margin tailwind.

Industrial Injury Prevention Maintains Momentum

The industrial injury prevention segment continued to stand out, posting revenue of $31.0 million, an 11.8% year-over-year increase, or 8.2% excluding acquisitions. Segment margin improved to 20.4% from 18.6%, expanding by 180 basis points and underscoring the strategic value of this higher-margin, employer-focused offering.

Adjusted EBITDA Growth and Guidance Reaffirmation

Adjusted EBITDA came in at $20.2 million for the quarter, up about $0.7 million versus the prior year and in line with internal expectations. Management reiterated its full-year 2026 adjusted EBITDA guidance of $102 million to $106 million and noted that the first quarter finished on budget, despite weather disruptions and cost pressures.

Strategic Deals Deepen PT and IIP Footprint

The company executed two notable transactions, buying a 50% stake in an eight-clinic physical therapy practice generating roughly $8 million in revenue and 60,000 annual visits. It also acquired a 70% interest in an industrial injury prevention business with about $7 million in revenue and spent approximately $14 million to repurchase noncontrolling interests, tightening alignment with key partners.

New Credit Facility Enhances Financial Flexibility

U.S. Physical Therapy bolstered its balance sheet capacity by closing a new five-year, $450 million credit facility that is larger and priced more favorably than the prior arrangement. This expanded borrowing base gives the company greater flexibility to fund acquisitions, invest in technology, and return capital, even as leverage has moved higher.

Operational and Technology Initiatives Rolling Out

The company is rolling out a semi-virtual front desk model, AI-assisted ambient documentation, and expanded cash-based offerings such as laser, shockwave, and dry needling across its leading partners. Hospital affiliations are ramping, with onboarding underway at NYU and other systems, and a Workday ERP implementation is in progress with completion targeted by the end of 2027.

Workforce Retention Improves Staffing Stability

Turnover has fallen below 18%, the lowest level the company has recorded, which management highlighted as a critical enabler for growth. Better retention should help clinics handle rising visit volumes, reduce reliance on contract labor, and support service quality as the company enters busier seasonal periods.

Weather Disruptions Hit Visits and Revenue

Severe weather proved costly in the quarter, with about 31,000 patient visits lost due to storm-related closures and disruptions. Management estimated the weather impact at roughly $3.3 million in lost revenue, with additional margin drag because payroll and other fixed costs continued even when clinics were shut.

Physical Therapy Margins Under Pressure

Adjusted physical therapy margin declined to 16.1% from 16.8% in the prior year period, a compression of roughly 70 basis points. Adjusted operating costs per visit rose 1.7% to $90.31 from $88.77, reflecting inflationary pressures and investments that have not yet been fully offset by volume and pricing gains.

Net Income and GAAP EPS Weaken on Revaluations

Net income attributable to shareholders dropped to $5.0 million from $9.9 million a year earlier, and the company reported a GAAP loss per share of $0.12 compared with earnings of $0.80. Management pointed to revaluation of redeemable noncontrolling interests and contingent earnout remeasurements as primary drivers of the GAAP per-share decline, despite relatively steady operating trends.

Corporate and Operating Costs Move Higher

Corporate expense as a share of revenue climbed to 8.8% from 8.5%, while payroll cost per visit increased to $64.20 from $63.53. Rent, supplies, and other operating items also ran higher, in part due to contract labor usage and upfront spending on technology and strategic initiatives that are expected to pay off over time.

Tax Rate and Interest Expense Add to Headwinds

The company’s income tax rate rose to 32.3% from 28.1%, elevated by discrete tax items on a lower pretax income base, which magnified their impact. Interest expense increased to $2.8 million from $2.3 million, reflecting cash outlays for acquisitions and noncontrolling interest purchases that have temporarily raised borrowing levels.

Cash Levels Decline as Leverage Rises

Cash and cash equivalents ended the quarter at $28 million, down from $36 million at year-end, while total borrowings increased to $204 million from $162 million. Management attributed the movement primarily to the funding of recent acquisitions and partner buyouts, noting that the new credit facility provides additional liquidity for future investments.

Medicaid Rate Softness Requires Vigilance

Leadership acknowledged a small drop in the blended Medicaid rate compared with the prior year, a reminder that reimbursement dynamics remain fluid. The company plans to closely monitor regional payer mix and state-level pricing changes to avoid unexpected pressure in markets where Medicaid is a more meaningful revenue contributor.

Seasonality Heightens Back-Half Execution Risk

First-quarter results represented about 19% of the company’s full-year adjusted EBITDA cadence, slightly lower than in past years, increasing the importance of second-half performance. Management underscored that achieving guidance will require a strong ramp in hospital and hospital-affiliation volumes, alongside continued execution on technology and productivity initiatives.

Guidance and Outlook

Management reaffirmed its full-year 2026 adjusted EBITDA outlook of $102 million to $106 million, citing on-budget first-quarter results and growing industrial injury prevention margins as key supports. They expect hospital alliances, semi-virtual front desks, AI documentation tools, and expanded cash-based programs to ramp through the year, with hospital initiatives alone projected to reach roughly $7 million on an annualized basis by the fourth quarter.

U.S. Physical Therapy’s earnings call painted a picture of a business growing revenue and visits while investing heavily in technology, partnerships, and new programs that temporarily weigh on margins. Investors will be watching to see whether hospital affiliations and operational initiatives deliver the second-half uplift needed to meet guidance, but management’s reaffirmed outlook and improved retention suggest confidence in the strategy.